Dodson, A., Okonji, D., Assersohn, L., Rigg, A., Sheri, A., Turner, N., . . . Dowsett, M. (2017). Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer. Breast Cancer Res Treat.

Dodson, Andrew, David Okonji, Laura Assersohn, Anne Rigg, Amna Sheri, Nick Turner, Ian Smith, Marina Parton, and Mitch Dowsett. "Discordance between Oncotype DX Recurrence Score and RSPC for Predicting Residual Risk of Recurrence in ER-positive Breast Cancer." Breast Cancer Res Treat 2017.

Dodson, Andrew, et al. "Discordance between Oncotype DX Recurrence Score and RSPC for Predicting Residual Risk of Recurrence in ER-positive Breast Cancer." Breast Cancer Res Treat 2017.